Webinar title: Liquid-based Detection of Copy Number Variations (CNVs) in Cancer
Date: Tuesday, April 6, 2021
Duration: 40 minutes
Copy number variations (CNVs) are often correlated with negative outcomes for cancer patients, however they are challenging to detect in liquid biopsy samples. Improvements in next generation sequencing (NGS) technology is enhancing the possibility of detecting these deleterious genomic alterations in circulating tumor DNA (ctDNA).
In this webinar, we highlighted the detection of CNVs using Predicine’s proprietary liquid biopsy platform, and present case studies demonstrating the utility of panel-based CNV detection in blood, and point to emerging CNVs as important biomarkers in precision oncology.
Learn more about our Clinician Access Program discussed in the webinar.
View other webinars from Predcine’s webinar series:
Webinar: Urine-based NGS liquid biopsy applications in bladder cancer